Bottles containing Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. These two preparations, of
Bottles containing Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. These two preparations, of different concentrations, are reconstituted before intravenous injection. Haemophilia is a hereditary disorder in which the blood clots very slowly, due to a deficiency in one of the blood coagulation factors. FVIII, also known as anti-haemophilic factor (AHF), is an essential blood clotting agent in humans.
Size: 5233px × 3489px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, -life, 8, 500, 1000, agent, ahf, alfa, anti-haemophilic, antihaemophilic, background, biotechnology, blood, body, bottle, bottles, chinese, cho, clotting, coagulation, concentrate, concentration, cut, cut-, cut-outs, cutout, cutouts, drug, drugs, engineered, engineering, factor, fviii, genetic, genetically, gm, gmo, haematological, haematology, haemophilia, haemophiliac, hamster, healthcare, hematology, hemophilia, hemophiliac, human, injection, intravenous, iu, iv, life, medical, medication, medicine, modification, moroctocog, outs, ovary, pharmaceutical, pharmaceuticals, pharmaceutics, pharmacological, pharmacology, powder, prescription, product, recombinant, reconstitution, refacto, shot, studio, therapy, treatment, viii, white
